BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9

• Press Releases

  Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor

  January 9, 2026

   · 

  11 min read
• Press Releases

  PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell

  January 9, 2026

   · 

  5 min read
• Press Releases

  Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock

  January 9, 2026

   · 

  4 min read
• Press Releases

  Akari Therapeutics to Present at the 2026 Biotech Showcase

  January 9, 2026

   · 

  2 min read
• Press Releases

  VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses

  January 9, 2026

   · 

  15 min read
• Press Releases

  Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium

  January 9, 2026

   · 

  10 min read
• Press Releases

  GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset

  January 9, 2026

   · 

  7 min read
• Press Releases

  A2 Biotherapeutics Announces FDA Clearance of IND for A2B543 for Treatment of Adults with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors that Express Mesothelin and Have Lost HLA-A*02 Expression

  January 9, 2026

   · 

  5 min read
• Press Releases

  MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease

  January 9, 2026

   · 

  7 min read
• Press Releases

  ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY PLATFORM

  January 9, 2026

   · 

  3 min read